Skip to main content
  • 4715 Accesses

Abstract

One of the clinical indications for administering cholinesterase inhibitors, or anticholinesterases, is to reverse the effect of muscle relaxation by non-depolarizing neuromuscular blocking agents at the conclusion of surgery. The purpose of administering antimuscarinic drugs concomitantly with anticholinesterases is to minimize the muscarinic side effects associated with increased acetylcholine transmission at muscarinic receptors. In this chapter, we review anticholinesterase and anticholinergic pharmacology, including mechanism of action, dosing, and adverse effects. We discuss their clinical significance in both the surgical context and their indications outside the operating room. In addition, we briefly discuss the relaxant binding agent sugammadex and its future role in anesthesia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Glick DB. The autonomic nervous system. In: Miller RD, editor. Miller’s anesthesia. 7th ed. Orlando: Churchill Livingstone; 2009.

    Google Scholar 

  2. Pohanka M. Acetylcholinesterase inhibitors; a patent review (2008-present). Expert Opin Ther Pat. 2012;22:871–86. doi:10.1517/13543776.2012.701620.

    Article  CAS  PubMed  Google Scholar 

  3. Naguib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, editor. Miller’s anesthesia. 7th ed. Orlando: Churchill Livingstone; 2009.

    Google Scholar 

  4. Donati F, Bevan DR. Neuromuscular blocking agents. In: Barash PG, editor. Clinical anesthesia. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.

    Google Scholar 

  5. Katzung BG. Cholinoceptor-blocking drugs. In: Basic and clinical pharmacology. 12th ed. New York: McGraw-Hill; 2011.

    Google Scholar 

  6. Morgan GE, Mikhail MS. Cholinesterase inhibitors. In: Clinical anesthesiology. 4th ed. New York: McGraw-Hill; 2006.

    Google Scholar 

  7. Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesth Analg. 1999;89:333–9.

    CAS  PubMed  Google Scholar 

  8. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg. 1995;80:1168–74.

    CAS  PubMed  Google Scholar 

  9. Saitoh Y, Toyooka H, Amaha K. Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neuroleptanaesthesia. Br J Anaesth. 1993;70:402–4.

    Article  CAS  PubMed  Google Scholar 

  10. Baurain MJ, D’Hollander AA, Melot C, et al. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology. 1991;74:474–8.

    Article  CAS  PubMed  Google Scholar 

  11. Burkett L, Bikhazi GZB, Thomas Jr KC, et al. Mutual potentiation of the neuromuscular effects of antibiotics and relaxants. Anesth Analg. 1979;58:107–15.

    Article  CAS  PubMed  Google Scholar 

  12. Sinatra RS, Philip BK, Naulty JS, Ostheimer GW. Prolonged neuromuscular blockade with vecuronium in a patient treated with magnesium sulfate. Anesth Analg. 1985;64:1220–2.

    Article  CAS  PubMed  Google Scholar 

  13. Usubiaga JE, Wikinski JA, Morales RL. Interaction of intravenously administered procaine, lidocaine and succinylcholine in anesthetized subjects. Anesth Analg. 1967;46:39–45.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Sim MD .

Editor information

Editors and Affiliations

Chemical Structures

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sim, A., Vick, A. (2015). Reversal Agents. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8948-1_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8947-4

  • Online ISBN: 978-1-4614-8948-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics